These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 30062974)
1. Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report. Shukkoor AA; Thangavelu S; George NE; Priya S Curr Drug Saf; 2019; 14(1):37-39. PubMed ID: 30062974 [TBL] [Abstract][Full Text] [Related]
2. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium. Hoogeveen RM; van der Bom T; de Boer HH; Thurlings RM; Wind BS; de Vries HJ; van Lent AU; Beuers U; van der Wal AC; Nellen FJ Neth J Med; 2016 Feb; 74(2):89-92. PubMed ID: 26951355 [TBL] [Abstract][Full Text] [Related]
3. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan. Sheen YS; Chu CY; Wang SH; Tsai TF J Dermatolog Treat; 2009; 20(6):340-3. PubMed ID: 19954390 [TBL] [Abstract][Full Text] [Related]
4. Dapsone syndrome with acute renal failure during leprosy treatment: case report. Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852 [TBL] [Abstract][Full Text] [Related]
5. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy. Craig J; MacRae C; Melvin RG; Boggild AK Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953 [TBL] [Abstract][Full Text] [Related]
6. Dapsone induced cholangitis as a part of dapsone syndrome: a case report. Itha S; Kumar A; Dhingra S; Choudhuri G BMC Gastroenterol; 2003 Aug; 3():21. PubMed ID: 12911838 [TBL] [Abstract][Full Text] [Related]
7. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy. Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479 [TBL] [Abstract][Full Text] [Related]
9. Dapsone hypersensitivity syndrome among leprosy patients in China. Tian W; Shen J; Zhou M; Yan L; Zhang G Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255 [TBL] [Abstract][Full Text] [Related]
10. Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. Krismawati H; Irwanto A; Pongtiku A; Irwan ID; Maladan Y; Sitanggang YA; Wahyuni T; Tanjung R; Sun Y; Liu H; Zhang F; Oktavian A; Liu J PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008746. PubMed ID: 33064728 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy. Liu H; Wang Z; Bao F; Wang C; Sun L; Zhang H; Yu G; Mi Z; Li J; Li L; Zhao Q; Yue Z; Zhao W; Yu W; Cao J; Xiong F; Wang Y; Chai Z; Cheng X; Zhang Y; Fu F; Lang X; Wang X; Irwanto A; Krismawati H; Fu X; Sun Y; You J; Liu J; Pan Q; Chu T; Liu D; Chen S; Shen J; Yan L; Zhang G; Liu J; Zhang F; ; Xiong L; Yang J; Li J; Ke W; Li M; Ning Y; Xiong J; Li M; Xiong M; Yang B; Duan Q; Wang H; Li W; Kuang Y; Li J; Wang L; Cao Q; Xiao P; Xiao B; Zhang L; Lin Z; Wang Y; Shen Y; Yan L; Wu W; Zheng H; Zhan X; Li W; Shang X; Xu Y; Liu Q JAMA Dermatol; 2019 Jun; 155(6):666-672. PubMed ID: 30916737 [TBL] [Abstract][Full Text] [Related]
12. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus. Pai S; Munshi R; Nayak C Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281 [TBL] [Abstract][Full Text] [Related]
13. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505 [TBL] [Abstract][Full Text] [Related]
14. A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic Testing. Wang N; Parimi L; Liu H; Zhang F Am J Trop Med Hyg; 2017 May; 96(5):1014-1018. PubMed ID: 28167593 [TBL] [Abstract][Full Text] [Related]
15. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. Rao PN; Lakshmi TS Lepr Rev; 2001 Mar; 72(1):57-62. PubMed ID: 11355519 [TBL] [Abstract][Full Text] [Related]
16. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E. Chogle A; Nagral A; Soni A; Agale S; Jamadar Z Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824 [TBL] [Abstract][Full Text] [Related]
17. Lack of Suspicion of Dapsone Hypersensitivity Syndrome in a Leprosy Patient: Case Report with Fatal Outcome. Ansah R; Arkoh EA; Quao BO; Groger M Res Rep Trop Med; 2023; 14():135-139. PubMed ID: 38170098 [TBL] [Abstract][Full Text] [Related]
18. Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome. Zhu KJ; He FT; Jin N; Lou JX; Cheng H J Clin Pharm Ther; 2009 Aug; 34(4):489-92. PubMed ID: 19583683 [TBL] [Abstract][Full Text] [Related]
19. Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome: Case Report. de Nardo Vanzela T; Bernardes Filho F; Wambier CG; Faria FM; Foss NT; Frade MAC Am J Dermatopathol; 2018 Mar; 40(3):205-208. PubMed ID: 28937434 [TBL] [Abstract][Full Text] [Related]
20. Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol. Krismawati H; Ferdiana A; Irwanto A; Budiawan T; Imaniar C; Wahyuni T; Singh P; Mieras L; Pongtiku A BMJ Open; 2022 May; 12(5):e057173. PubMed ID: 35545382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]